EUVIMEDEUVIMED entdecken
Vergleichsstudie

Real-world individual and comparative analysis of adverse event reporting for adalimumab and etanercept using public FDA adverse event reporting system data

Xiaoke Dou, Yan Dai, Li Zhu, Yun Lin, Yan Wu

Archives of Dermatological Research · 2024

DOI: 10.1007/s00403-024-03626-5 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Archives of Dermatological Research, 2024. Verfasst von Xiaoke Dou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. Hauptthemen laut MEDLINE: Adalimumab, Etanercept, Adverse Drug Reaction Reporting Systems, United States Food and Drug Administration. Die Arbeit nennt 57 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdalimumabEtanerceptAdverse Drug Reaction Reporting SystemsUnited States Food and Drug AdministrationHumansUnited StatesMaleFemaleBayes TheoremMiddle AgedAdultAlgorithms

Stichwörter der Autor:innen

AdalimumabAdverse eventsEtanerceptFAERSSerious outcomes

Substanzen

AdalimumabEtanercept

Autor:innen und Institutionen

  • Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
  • Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
  • Key Laboratory of Anesthesiology and Resuscitation, Huazhong University of Science and Technology, Ministry of Education, Wuhan, China.
  • Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277, Jiefang Avenue, Wuhan, 430022, China.
  • Department of Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277, Jiefang Avenue, Wuhan, 430022, China. wuyan5151@hust.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Dou, X., Dai, Y., Zhu, L., Lin, Y., & Wu, Y. (2024). Real-world individual and comparative analysis of adverse event reporting for adalimumab and etanercept using public FDA adverse event reporting system data. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-03626-5

Vancouver

Dou X, Dai Y, Zhu L, Lin Y, Wu Y. Real-world individual and comparative analysis of adverse event reporting for adalimumab and etanercept using public FDA adverse event reporting system data. Archives of Dermatological Research. 2024. doi:10.1007/s00403-024-03626-5

BibTeX
@article{Dou2024,
  author = {Dou, Xiaoke and Dai, Yan and Zhu, Li and Lin, Yun and Wu, Yan},
  title = {Real-world individual and comparative analysis of adverse event reporting for adalimumab and etanercept using public FDA adverse event reporting system data},
  journal = {Archives of Dermatological Research},
  year = {2024},
  doi = {10.1007/s00403-024-03626-5}
}
Kostenlos starten →